文献速递运动医学关节外科

肩关节镜下肱二头肌肌腱切断与固定术随机对照试验的统计稳健性:反向连续脆弱指数分析

Statistical Robustness of Randomized Controlled Trials Comparing Biceps Tenotomy Versus Tenodesis: A Reverse Continuous Fragility Index Analysis.
PubMed 文献 · Am J Sports Med · 2026-04-22

该系统综述与meta分析纳入7项随机对照试验共622例患者,采用反向连续脆弱指数(rCFI)评估肩关节镜下肱二头肌肌腱切断与固定术比较中非显著性结果的统计稳健性。结果显示主要结局平均rCFI为17.7(SD 8.6,范围4-26),反向脆弱商平均0.227(SD 0.104),提示这些非劣效结论具有中等稳健性。

要点

  • 7项RCT共622例患者,主要非显著结局平均rCFI为17.7,提示结论中等稳健。
  • 计算rCFI时57.14%(4/7)研究转为显著,固定组结局评分优于切断组。
  • 总失访55例,平均7.8例,无研究失访数超过其rCFI值。

核心结论

  • 肩关节镜下肱二头肌肌腱切断与固定术的高质量RCT大多显示临床结局的统计非劣效性。
  • 对这些非显著结果进行rCFI评估支持结论具有中等稳健性。

研究设计与样本

  • 系统综述与meta分析,证据等级1级。
  • 检索PubMed、Embase和Cochrane Library数据库,时间2004年至2025年9月,遵循PRISMA指南。
  • 纳入比较肩关节镜下肱二头肌肌腱固定术与切断术临床结局的随机对照试验。
  • 最终纳入7项研究共622例患者。
  • 计算主要非显著结局的rCFI并取均值,同时记录失访并计算反向连续脆弱商。

主要发现

  • 所有纳入研究主要结局的平均rCFI为17.7(SD 8.6,范围4-26)。
  • 计算rCFI时,4项(57.14%)研究报告结局转为显著,固定组结局评分高于切断组。
  • 总失访55例,各研究平均失访7.8例,无研究失访数大于其计算的rCFI。
  • 平均反向脆弱商为0.227(SD 0.104)。
  • 在合并肩袖修复的研究中,平均rCFI和反向脆弱商分别为18.25和0.163。

关键数值与推荐

  • 主要非显著结局平均rCFI为17.7(SD 8.6,范围4-26)。
  • 平均反向脆弱商为0.227(SD 0.104)。
  • 合并肩袖修复研究的平均rCFI为18.25,反向脆弱商为0.163。
  • 4项(57.14%)研究计算rCFI后结局转为显著,固定组评分更优。

临床怎么用

  • 肩关节镜下肱二头肌肌腱切断与固定术的临床结局非劣效结论具有中等统计稳健性,可支持临床决策。
  • 解释非显著结果时应考虑rCFI和反向脆弱商,以评估结论的稳健程度。
  • 失访数未超过rCFI,提示现有失访不太可能颠覆非显著结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reverse continuous fragility index (rCFI) is a statistical measure utilized to evaluate the relative robustness or fragility of nonstatistically significant findings of randomized controlled trials. Such studies comparing biceps tenotomy versus tenodesis during shoulder arthroscopy have generally shown similar clinical and functional outcomes between the treatments. PURPOSE: To evaluate the statistical robustness or fragility of nonsignificant outcomes of high-quality randomized controlled studies comparing clinical outcomes of biceps tenotomy versus tenodesis during shoulder arthroscopy. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 1. METHODS: The PubMed, Embase, and Cochrane Library databases were searched according to the PRISMA guidelines from 2004 to September 2025 with the following search strategy: "('biceps' OR 'biceps brachii' OR 'long head biceps') AND ('tenodesis' OR 'tenotomy') AND ('Randomized controlled trial' OR 'RCT')." Studies were included if they were randomized controlled trials that compared clinical outcomes of biceps tenodesis versus biceps tenotomy during shoulder arthroscopy. rCFI was calculated on the primary nonsignificant outcomes of all studies and averaged to obtain the mean rCFI. Loss to follow-up was recorded for each study. The reverse continuous fragility quotient was calculated to account for the study sample size. RESULTS: Seven studies with 622 patients were included in the final analysis. The mean rCFI of primary study outcomes of all included studies was 17.7 (SD, 8.6; range, 4-26). When rCFI was calculated, 4 (57.14%) of the 7 studies reported a now-significant outcome, with the tenodesis group having greater outcome scores as compared with the tenotomy group. The total loss to follow-up was 55, with a mean 7.8 across all studies. No studies reported a loss to follow-up that was greater than the calculated rCFI. The mean reverse fragility quotient was 0.227 (SD, 0.104). For studies comparing tenotomy versus tenodesis with concomitant rotator cuff repair, the mean rCFI and reverse fragility quotient were 18.25 and 0.163, respectively. CONCLUSION: High-quality randomized controlled trials comparing biceps tenotomy versus tenodesis during shoulder arthroscopy have largely demonstrated statistical noninferiority of clinical outcomes. The evaluation of rCFI of these nonstatistically significant results supports the moderate robustness of these conclusions.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Hu EY, Althoff AD, Cervantes JE, et al. Statistical Robustness of Randomized Controlled Trials Comparing Biceps Tenotomy Versus Tenodesis: A Reverse Continuous Fragility Index Analysis. Am J Sports Med. 2026. PMID: 42015691. doi:10.1177/03635465261440392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。